Wegovy may have highest eye stroke and sight loss risk of semaglutide GLP-1 agonists— Odds of ischaemic optic neuropathy(caused by inadequate/interrupted blood flow to the optic nerve, resulting in sudden vision loss in one or both eyes) nearly 5 times higher than among users of Ozempic
New Research Confirms Weight-Loss Drug Link With Sudden Vision Loss
Genetic profile may predict best response to weight-loss drug Wegovy